Renaissance Technologies
ETON icon

Renaissance Technologies’s Eton Pharmaceutcials ETON Stock Holding History

Renaissance Technologies’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.03M Sell
163,321
-42,379
-21% -$741K 0.01% 1496
2025
Q4 		$3.48M Sell
205,700
-118,921
-37% -$2.09M 0.01% 1547
2025
Q3 		$7.05M Sell
324,621
-81,279
-20% -$1.35M 0.01% 1291
2025
Q2 		$5.78M Buy
405,900
+131,900
+48% +$2.09M 0.01% 1432
2025
Q1 		$3.56M Buy
274,000
+80,900
+42% +$1.22M 0.01% 1641
2024
Q4 		$2.57M Buy
193,100
+109,700
+132% +$1.11M ﹤0.01% 1881
2024
Q3 		$500K Sell
83,400
-23,100
-22% -$97.6K ﹤0.01% 2791
2024
Q2 		$350K Buy
106,500
+41,469
+64% +$145K ﹤0.01% 2851
2024
Q1 		$244K Buy
65,031
+22,331
+52% +$97.5K ﹤0.01% 3159
2023
Q4 		$187K Sell
42,700
-500
-1% -$2K ﹤0.01% 3150
2023
Q3 		$180K Buy
43,200
+15,600
+57% +$60.2K ﹤0.01% 3123
2023
Q2 		$96K Buy
27,600
+14,200
+106% +$52.2K ﹤0.01% 3485
2023
Q1 		$52K Buy
+13,400
New +$48.9K ﹤0.01% 3655
2020
Q2 		– Sell
-36,283
Closed -$149K – 3534
2020
Q1 		$149K Buy
+36,283
New +$212K ﹤0.01% 3159

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Renaissance Technologies's ETON Position: Q1 2026 in Review

Renaissance Technologies reduced its Eton Pharmaceutcials (ETON) stake by 21% in Q1 2026, selling an estimated $741K and leaving 163,321 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #1496.

Renaissance Technologies first reported a position in ETON in Q1 2020 and has held it in 14 quarters since. The position peaked at $7.05M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Renaissance Technologies held 163,321 shares of Eton Pharmaceutcials worth $4.03M as of Q1 2026.
  • Renaissance Technologies sold 42,379 Eton Pharmaceutcials shares in Q1 2026, an estimated $741K.
  • Eton Pharmaceutcials made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1496 holding.
  • Renaissance Technologies first reported a position in Eton Pharmaceutcials in Q1 2020 and has held it in 14 quarters since.
  • Renaissance Technologies's Eton Pharmaceutcials position peaked at $7.05M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.